NCT03471741 Intensity Modulated Radiotherapy With Concomitant Boost in Breast Cancer Status COMPLETED Phase N/A
NCT03471663 A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer Status COMPLETED Phase PHASE1
NCT03468881 A Communication Skills Package to Prevent Fear of Cancer Recurrence Status UNKNOWN Phase N/A
NCT03465202 Association of Capecitabine Pharmacokinetics and Toxicity With Aging Status UNKNOWN Phase PHASE4
NCT03464942 Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT03462251 Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line Status COMPLETED Phase PHASE3
NCT03457506 Intra-individual Comparison of Conventional and Digital PET/CT Scanners Status COMPLETED Phase NA
NCT03457467 Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast Cancer Status UNKNOWN Phase PHASE2
NCT03456661 Comparison Between Levobupivacaine and Levobupivacaine With Dexmedetomidine in Ultrasound Guided Pectoral Nerve Block Status TERMINATED Phase PHASE4
NCT03456427 Patient-Assisted Compression in 3D - Impact on Image Quality and Workflow Status COMPLETED Phase NA
NCT03456167 Mobile App Postoperative Home Monitoring After Enhanced Recovery Oncologic Surgery Status COMPLETED Phase NA
NCT03455270 G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer Status COMPLETED Phase PHASE1
NCT03454282 Impact of Dietary Intervention on Tumor Immunity: the DigesT Trial Status UNKNOWN Phase NA
NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry Status RECRUITING Phase N/A
NCT03451162 Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast Cancer Status COMPLETED Phase PHASE1
NCT03449303 Chemotherapy-Induced Peripheral Neuropathy-Essential Oil Intervention Status COMPLETED Phase NA